市場調查報告書

細胞化驗分析的全球市場

Cell Based Assays

出版商 Global Industry Analysts, Inc. 商品編碼 898200
出版日期 內容資訊 英文 234 Pages
商品交期: 最快1-2個工作天內
價格
細胞化驗分析的全球市場 Cell Based Assays
出版日期: 2020年09月01日內容資訊: 英文 234 Pages
簡介

本報告提供全球細胞化驗分析 (CBA) 市場相關分析,彙整整體市場規模的實際成果值·預測值,及主要推動及阻礙市場要素,各用途·各產品種類·各最終用途及各企業的市場佔有率趨勢 (過去9年·今後8年份),今後的市場成長的方向性,各地區·主要國家的市場詳細趨勢等調查,主要企業的簡介等資訊,為您概述為以下內容。

第1章 分析方法

第2章 摘要整理

  • 市場概要
    • 各企業的市場佔有率結構 (最新值·預測值)
    • 各市場區隔的市場佔有率結構 (最新值·預測值)
  • 代表性企業分析
  • 市場趨勢與促進因素
  • 全球市場的未來展望

第3章 市場分析

  • 各地區的市場分析
  • 美國
    • 市場基本資料
    • 各企業市場佔有率
    • 細胞化驗分析的市場規模 (實際成果值·預測值)
    • 各用途 (公共事業,商業,製造業等)
    • 各產品種類的市場規模 (實際成果值·預測值)
    • 各最終用途的市場規模 (實際成果值·預測值)
  • 加拿大
  • 日本
  • 中國
  • 歐洲 (法國,德國,義大利,英國等)
  • 亞太地區
  • 其他的國家 (RoW)

第4章 企業

  • CELL BIOLABS
  • CELL SIGNALING TECHNOLOGY
  • CHARLES RIVER LABORATORIES INTERNATIONAL
  • CISBIO BIOASSAYS
  • DANAHER CORPORATION
  • DISCOVERX CORPORATION
  • GENERAL ELECTRIC COMPANY
  • LONZA GROUP AG
  • MERCK KGAA
  • PERKINELMER
  • PROMEGA CORPORATION
  • THERMO FISHER SCIENTIFIC

第5章 相關分析

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP10937

Global Cell Based Assays Market to Reach $24.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Cell Based Assays estimated at US$15.2 Billion in the year 2020, is projected to reach a revised size of US$24.2 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$10.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $4.5 Billion, While China is Forecast to Grow at 6.4% CAGR

The Cell Based Assays market in the U.S. is estimated at US$4.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Services Segment to Record 7% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 7.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$1.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.8 Billion by the year 2027.We bring years of research experience to this 6th edition of our report. The 234-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Becton, Dickinson and Company
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories International, Inc.
  • Cisbio Bioassays
  • Danaher Corporation
  • Discoverx Corporation
  • General Electric Company
  • Lonza Group Ltd.
  • Merck KgaA
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Cell Based Assays Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Cell Based Assays Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 2: Cell Based Assays Global Retrospective Market Scenario in US$ Million by Region/Country: 2012
    • TABLE 3: Cell Based Assays Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS
    • TABLE 4: Consumables (Product Type) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 5: Consumables (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 6: Consumables (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 7: Instruments (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 8: Instruments (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 9: Instruments (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 10: Services (Product Type) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 11: Services (Product Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 12: Services (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 13: Software (Product Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 14: Software (Product Type) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 15: Software (Product Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 16: Drug Discovery (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020
    • TABLE 17: Drug Discovery (Application) Global Historic Analysis in US$ Million by Region/Country: 2012
    • TABLE 18: Drug Discovery (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 19: Predictive Toxicology (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through
    • TABLE 20: Predictive Toxicology (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to
    • TABLE 21: Predictive Toxicology (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and
    • TABLE 22: ADME Studies (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020
    • TABLE 23: ADME Studies (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012
    • TABLE 24: ADME Studies (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 25: Other Applications (Application) Worldwide Sales in US$ Million by Region/Country: 2020
    • TABLE 26: Other Applications (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012
    • TABLE 27: Other Applications (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS
    • TABLE 28: Pharmaceutical & Biotechnology Companies (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020
    • TABLE 29: Pharmaceutical & Biotechnology Companies (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2012
    • TABLE 30: Pharmaceutical & Biotechnology Companies (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 31: Academic & Government Institutions (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2020
    • TABLE 32: Academic & Government Institutions (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012
    • TABLE 33: Academic & Government Institutions (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS
    • TABLE 34: Contract Research Organizations (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020
    • TABLE 35: Contract Research Organizations (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012
    • TABLE 36: Contract Research Organizations (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 37: Other End-Uses (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through
    • TABLE 38: Other End-Uses (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to
    • TABLE 39: Other End-Uses (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Cell Based Assays Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 40: United States Cell Based Assays Market Estimates and Projections in US$ Million by Product Type: 2020 to
    • TABLE 41: Cell Based Assays Market in the United States by Product Type: A Historic Review in US$ Million for 2012
    • TABLE 42: United States Cell Based Assays Market Share Breakdown by Product Type: 2012 VS 2020 VS
    • TABLE 43: United States Cell Based Assays Latent Demand Forecasts in US$ Million by Application: 2020 to
    • TABLE 44: Cell Based Assays Historic Demand Patterns in the United States by Application in US$ Million for 2012
    • TABLE 45: Cell Based Assays Market Share Breakdown in the United States by Application: 2012 VS 2020 VS
    • TABLE 46: United States Cell Based Assays Latent Demand Forecasts in US$ Million by End-Use: 2020 to
    • TABLE 47: Cell Based Assays Historic Demand Patterns in the United States by End-Use in US$ Million for 2012
    • TABLE 48: Cell Based Assays Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS
  • CANADA
    • TABLE 49: Canadian Cell Based Assays Market Estimates and Forecasts in US$ Million by Product Type: 2020 to
    • TABLE 50: Canadian Cell Based Assays Historic Market Review by Product Type in US$ Million: 2012
    • TABLE 51: Cell Based Assays Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and
    • TABLE 52: Canadian Cell Based Assays Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 53: Cell Based Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012
    • TABLE 54: Canadian Cell Based Assays Market Share Analysis by Application: 2012 VS 2020 VS
    • TABLE 55: Canadian Cell Based Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
    • TABLE 56: Cell Based Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012
    • TABLE 57: Canadian Cell Based Assays Market Share Analysis by End-Use: 2012 VS 2020 VS
  • JAPAN
    • TABLE 58: Japanese Market for Cell Based Assays: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020
    • TABLE 59: Cell Based Assays Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2012
    • TABLE 60: Japanese Cell Based Assays Market Share Analysis by Product Type: 2012 VS 2020 VS
    • TABLE 61: Japanese Demand Estimates and Forecasts for Cell Based Assays in US$ Million by Application: 2020 to
    • TABLE 62: Japanese Cell Based Assays Market in US$ Million by Application: 2012
    • TABLE 63: Cell Based Assays Market Share Shift in Japan by Application: 2012 VS 2020 VS
    • TABLE 64: Japanese Demand Estimates and Forecasts for Cell Based Assays in US$ Million by End-Use: 2020 to
    • TABLE 65: Japanese Cell Based Assays Market in US$ Million by End-Use: 2012
    • TABLE 66: Cell Based Assays Market Share Shift in Japan by End-Use: 2012 VS 2020 VS
  • CHINA
    • TABLE 67: Chinese Cell Based Assays Market Growth Prospects in US$ Million by Product Type for the Period 2020
    • TABLE 68: Cell Based Assays Historic Market Analysis in China in US$ Million by Product Type: 2012
    • TABLE 69: Chinese Cell Based Assays Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 70: Chinese Demand for Cell Based Assays in US$ Million by Application: 2020 to
    • TABLE 71: Cell Based Assays Market Review in China in US$ Million by Application: 2012
    • TABLE 72: Chinese Cell Based Assays Market Share Breakdown by Application: 2012 VS 2020 VS
    • TABLE 73: Chinese Demand for Cell Based Assays in US$ Million by End-Use: 2020 to
    • TABLE 74: Cell Based Assays Market Review in China in US$ Million by End-Use: 2012
    • TABLE 75: Chinese Cell Based Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS
  • EUROPE
    • Market Facts & Figures
    • European Cell Based Assays Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 76: European Cell Based Assays Market Demand Scenario in US$ Million by Region/Country: 2020
    • TABLE 77: Cell Based Assays Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012
    • TABLE 78: European Cell Based Assays Market Share Shift by Region/Country: 2012 VS 2020 VS
    • TABLE 79: European Cell Based Assays Market Estimates and Forecasts in US$ Million by Product Type: 2020
    • TABLE 80: Cell Based Assays Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2012
    • TABLE 81: European Cell Based Assays Market Share Breakdown by Product Type: 2012 VS 2020 VS
    • TABLE 82: European Cell Based Assays Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 83: Cell Based Assays Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012
    • TABLE 84: European Cell Based Assays Market Share Analysis by Application: 2012 VS 2020 VS
    • TABLE 85: European Cell Based Assays Addressable Market Opportunity in US$ Million by End-Use: 2020
    • TABLE 86: Cell Based Assays Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012
    • TABLE 87: European Cell Based Assays Market Share Analysis by End-Use: 2012 VS 2020 VS
  • FRANCE
    • TABLE 88: Cell Based Assays Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 89: French Cell Based Assays Historic Market Scenario in US$ Million by Product Type: 2012
    • TABLE 90: French Cell Based Assays Market Share Analysis by Product Type: 2012 VS 2020 VS
    • TABLE 91: Cell Based Assays Quantitative Demand Analysis in France in US$ Million by Application: 2020
    • TABLE 92: French Cell Based Assays Historic Market Review in US$ Million by Application: 2012
    • TABLE 93: French Cell Based Assays Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and
    • TABLE 94: Cell Based Assays Quantitative Demand Analysis in France in US$ Million by End-Use: 2020
    • TABLE 95: French Cell Based Assays Historic Market Review in US$ Million by End-Use: 2012
    • TABLE 96: French Cell Based Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
  • GERMANY
    • TABLE 97: Cell Based Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020
    • TABLE 98: German Cell Based Assays Historic Market Analysis in US$ Million by Product Type: 2012
    • TABLE 99: German Cell Based Assays Market Share Breakdown by Product Type: 2012 VS 2020 VS
    • TABLE 100: Cell Based Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020
    • TABLE 101: German Cell Based Assays Market in Retrospect in US$ Million by Application: 2012
    • TABLE 102: Cell Based Assays Market Share Distribution in Germany by Application: 2012 VS 2020 VS
    • TABLE 103: Cell Based Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020
    • TABLE 104: German Cell Based Assays Market in Retrospect in US$ Million by End-Use: 2012
    • TABLE 105: Cell Based Assays Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS
  • ITALY
    • TABLE 106: Italian Cell Based Assays Market Growth Prospects in US$ Million by Product Type for the Period 2020
    • TABLE 107: Cell Based Assays Historic Market Analysis in Italy in US$ Million by Product Type: 2012
    • TABLE 108: Italian Cell Based Assays Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 109: Italian Demand for Cell Based Assays in US$ Million by Application: 2020 to
    • TABLE 110: Cell Based Assays Market Review in Italy in US$ Million by Application: 2012
    • TABLE 111: Italian Cell Based Assays Market Share Breakdown by Application: 2012 VS 2020 VS
    • TABLE 112: Italian Demand for Cell Based Assays in US$ Million by End-Use: 2020 to
    • TABLE 113: Cell Based Assays Market Review in Italy in US$ Million by End-Use: 2012
    • TABLE 114: Italian Cell Based Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS
  • UNITED KINGDOM
    • TABLE 115: United Kingdom Market for Cell Based Assays: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020
    • TABLE 116: Cell Based Assays Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2012
    • TABLE 117: United Kingdom Cell Based Assays Market Share Analysis by Product Type: 2012 VS 2020 VS
    • TABLE 118: United Kingdom Demand Estimates and Forecasts for Cell Based Assays in US$ Million by Application: 2020 to
    • TABLE 119: United Kingdom Cell Based Assays Market in US$ Million by Application: 2012
    • TABLE 120: Cell Based Assays Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS
    • TABLE 121: United Kingdom Demand Estimates and Forecasts for Cell Based Assays in US$ Million by End-Use: 2020 to
    • TABLE 122: United Kingdom Cell Based Assays Market in US$ Million by End-Use: 2012
    • TABLE 123: Cell Based Assays Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS
  • REST OF EUROPE
    • TABLE 124: Rest of Europe Cell Based Assays Market Estimates and Forecasts in US$ Million by Product Type: 2020
    • TABLE 125: Cell Based Assays Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2012
    • TABLE 126: Rest of Europe Cell Based Assays Market Share Breakdown by Product Type: 2012 VS 2020 VS
    • TABLE 127: Rest of Europe Cell Based Assays Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 128: Cell Based Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012
    • TABLE 129: Rest of Europe Cell Based Assays Market Share Analysis by Application: 2012 VS 2020 VS
    • TABLE 130: Rest of Europe Cell Based Assays Addressable Market Opportunity in US$ Million by End-Use: 2020
    • TABLE 131: Cell Based Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012
    • TABLE 132: Rest of Europe Cell Based Assays Market Share Analysis by End-Use: 2012 VS 2020 VS
  • ASIA-PACIFIC
    • TABLE 133: Cell Based Assays Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 134: Asia-Pacific Cell Based Assays Historic Market Scenario in US$ Million by Product Type: 2012
    • TABLE 135: Asia-Pacific Cell Based Assays Market Share Analysis by Product Type: 2012 VS 2020 VS
    • TABLE 136: Cell Based Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020
    • TABLE 137: Asia-Pacific Cell Based Assays Historic Market Review in US$ Million by Application: 2012
    • TABLE 138: Asia-Pacific Cell Based Assays Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and
    • TABLE 139: Cell Based Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020
    • TABLE 140: Asia-Pacific Cell Based Assays Historic Market Review in US$ Million by End-Use: 2012
    • TABLE 141: Asia-Pacific Cell Based Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
  • REST OF WORLD
    • TABLE 142: Rest of World Cell Based Assays Market Estimates and Forecasts in US$ Million by Product Type: 2020 to
    • TABLE 143: Rest of World Cell Based Assays Historic Market Review by Product Type in US$ Million: 2012
    • TABLE 144: Cell Based Assays Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and
    • TABLE 145: Rest of World Cell Based Assays Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 146: Cell Based Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012
    • TABLE 147: Rest of World Cell Based Assays Market Share Analysis by Application: 2012 VS 2020 VS
    • TABLE 148: Rest of World Cell Based Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
    • TABLE 149: Cell Based Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012
    • TABLE 150: Rest of World Cell Based Assays Market Share Analysis by End-Use: 2012 VS 2020 VS

IV. COMPETITION

  • Total Companies Profiled: 42